CLINICAL_TRIALS
trial_result
· 2020-01-14
Clinical Trial Update: Remediation of Age-related Cognitive Decline: Vortioxetine and Cognitive Training [Phase 4]
Summary
Phase 4 clinical trial investigating vortioxetine with cognitive training for age-related cognitive decline has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Washington University School of Medicine | Conditions: Age-related Cognitive Decline | Phase 4 | Status: COMPLETED | Results posted: 2020-01-14